Effect of Once-Weekly Epoetin Beta on Survival in Patients With Metastatic Breast Cancer Receiving Anthracycline- and/or Taxane-Based Chemotherapy: Results of the Breast Cancer—Anemia and the Value of Erythropoietin (BRAVE) Study

Effects of Epoetin Alfa on Hematologic Parameters and Quality of Life in Cancer Patients Receiving Nonplatinum Chemotherapy: Results of a Randomized, Double-Blind, Placebo-Controlled Trial

2001 • 996 citations

Chemotherapy-Induced Anemia in Adults: Incidence and Treatment

1999 • 918 citations

Anemia as an independent prognostic factor for survival in patients with cancer: a systemic, quantitative review.

2001 • 828 citations

Anemia as an independent prognostic factor for survival in patients with cancer

2001 • 698 citations

Maintaining Normal Hemoglobin Levels With Epoetin Alfa in Mainly Nonanemic Patients With Metastatic Breast Cancer Receiving First-Line Chemotherapy: A Survival Study

2005 • 667 citations

Recombinant Human Erythropoietins and Cancer Patients: Updated Meta-Analysis of 57 Studies Including 9353 Patients

2006 • 557 citations

Double-Blind, Placebo-Controlled, Randomized Phase III Trial of Darbepoetin Alfa in Lung Cancer Patients Receiving Chemotherapy

2002 • 482 citations

Breast cancer trial with erythropoietin terminated unexpectedly

2003 • 470 citations

Relationship between changes in hemoglobin level and quality of life during chemotherapy in anemic cancer patients receiving epoetin alfa therapy

2002 • 428 citations

Use of Epoetin in Patients With Cancer: Evidence-Based Clinical Practice Guidelines of the American Society of Clinical Oncology and the American Society of Hematology

2002 • 419 citations

EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer: 2006 update

2006 • 401 citations

EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer

2004 • 338 citations

Impact of hemoglobin level and use of recombinant erythropoietin on efficacy of preoperative chemoradiation therapy for squamous cell carcinoma of the oral cavity and oropharynx

2001 • 264 citations

Recombinant Human Erythropoietin and Overall Survival in Cancer Patients: Results of a Comprehensive Meta-analysis

2005 • 240 citations

Weekly Epoetin Alfa Maintains Hemoglobin, Improves Quality of Life, and Reduces Transfusion in Breast Cancer Patients Receiving Chemotherapy

2004 • 167 citations

Management of Cancer-Related Anemia in Patients with Breast or Gynecologic Cancer: New Insights Based on Results from the European Cancer Anemia Survey

2005 • 68 citations

Darbepoetin Alfa for the Treatment of Chemotherapy-Induced Anemia: Disease Progression and Survival Analysis From Four Randomized, Double-Blind, Placebo-Controlled Trials

2005 • 63 citations

Impact of epoetin‐β on survival of patients with lymphoproliferative malignancies: long‐term follow up of a large randomized study*

2005 • 59 citations

Effect of treatment with epoetin beta on short-term tumour progression and survival in anaemic patients with cancer: a meta-analysis

2006 • 49 citations

Erythropoietin enhances radiation treatment efficacy in patients with pelvic malignancies. final results of a randomized phase III study

2001 • 44 citations

Benefits of Epoetin Alfa in Anemic Breast Cancer Patients Receiving Chemotherapy

2002 • 38 citations

Epoetin alfa improves survival after chemoradiation for Stage III esophageal cancer: Final results of a prospective observational study

2006 • 28 citations

Epoetin beta (NeoRecormon) therapy in patients with solid tumours receiving platinum and non-platinum chemotherapy: a meta-analysis.

2006 • 26 citations

Treatment of Chemotherapy-Induced Anemia in Breast Cancer: Results of a Randomized Controlled Trial of Darbepoetin Alfa 200 μg Every 2 Weeks Versus Epoetin Alfa 40,000 U Weekly

2005 • 26 citations

Erythropoietin Treatment in Metastatic Breast Cancer

2002 • 25 citations

Genitourinary cancer

2001 • 3 citations

Cited By (0)

Loading...